VERADIGM INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.55 USD | -3.82% |
|
-2.58% | -28.03% |
| 04-03 | Veradigm and Vim Announce Strategic Collaboration to Improve Payer-Provider Collaboration | CI |
| 03-19 | Deutsche Bank Downgrades Veradigm to Hold From Buy, Adjusts Price Target to $10 From $15 | MT |
Presentation Operator MessageOperator (Operator)Good evening. My name is Wendy, and I'll be yo...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Veradigm Inc. is a healthcare data and technology solutions technology company. The Company is focused on research, analytics, and building scalable data-driven solutions. It combines data-driven clinical insights with actionable tools to enable healthcare stakeholders improve the value of healthcare delivery. The Veradigm Network features a dynamic community of solutions and partners providing advanced insights, technology, and data-driven solutions for the healthcare provider, payer, and biopharma markets. Its Veradigm Network Solutions include Veradigm Real World Data, Veradigm Real World Evidence, Veradigm Digital Health Media, and Evalytica. Its health plan and payer solutions include eCHART COURIER, Veradigm Payer Insights, and Risk Adjustment & Quality Analytics. Its healthcare provider solutions include Veradigm Practice Management, Veradigm Payerpath, and Electronic Health Records. It also provides full-service revenue cycle management.
Related indices
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
7.55
USD
Average target price
15
USD
Spread / Average Target
+98.68%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -28.03% | 1.33B | |
| +9.22% | 33.88B | |
| +21.99% | 8.35B | |
| +31.37% | 4.24B | |
| -30.15% | 2.67B | |
| -19.11% | 1.45B | |
| -33.21% | 1.16B | |
| +13.85% | 1B | |
| -34.50% | 892M | |
| -24.11% | 699M |
- Stock Market
- Equities
- MDRX Stock
- News Veradigm Inc.
- Transcript : Allscripts Healthcare Solutions, Inc., Q1 2012 Earnings Call, Apr 26, 2012
